Michael Overdorf
Corporate Officer/Principal en ANNEXON, INC. .
Fortuna: 614 046 $ al 31/03/2024
Perfil
Michael Overdorf is currently the Chief Business Officer & Executive Vice President at Annexon, Inc. Prior to his current position, he worked at Eli Lilly & Co. as the COO-Bio-Medicines Business Unit from 2001 to 2020.
He completed his undergraduate degree at Wabash College in 1992 and obtained an MBA from Harvard Business School in 1999.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ANNEXON, INC.
0.10% | 20/02/2024 | 85 641 ( 0.10% ) | 614 046 $ | 31/03/2024 |
Cargos activos de Michael Overdorf
| Empresas | Cargo | Inicio |
|---|---|---|
| ANNEXON, INC. | Corporate Officer/Principal | 30/07/2020 |
Antiguos cargos conocidos de Michael Overdorf.
| Empresas | Cargo | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/07/2020 |
Formación de Michael Overdorf.
| Wabash College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ANNEXON, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Overdorf
